Connect your AI

Scholar Rock SRRK Prepaid & Other Current

Prepaid & Other Current at other companies

BiogenBIIB

$1.17B+54.3%

PTC TherapeuticsPTCT

$66.05M+15.8%

Travere Therapeutics, Inc.TVTX

$34.35M+152%

Cogent Biosciences, Inc.COGT

$11.43M+58.2%

BridgeBio PharmaBBIO

$62.91M+77.9%

Arrowhead ResearchARWR

$21.72M-8.6%

Other financials

Income statement

Revenue-—

Operating income-$102.0M-32.3%

Net income-$105.5M-41.2%

EPS (diluted)-$0.83-23.9%

Balance sheet

Cash & equivalents$430.5M+212%

Total debt$205.7M+226%

Total equity$276.0M-11.6%

Total assets$535.3M+31.3%

Cash flow

Operating cash flow-$82.1M-4.4%

CapEx$68.0K-74.9%

Free cash flow-$82.2M-4.1%

Valuation

Market cap$5.67B+85.5%

Enterprise value$5.45B+82.6%

P/S170.9×—

Profitability

Operating margin-231.8%—

Net margin-236.9%—

FCF margin-309.1%—

Returns & leverage

Return on equity-138.9%+60.1pp

Debt / equity0.7×+0.5×

Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Scholar Rock's prepaid & other current?: Scholar Rock (SRRK) reported prepaid & other current of $35.34M in Q1 2026.
How has Scholar Rock's prepaid & other current changed year-over-year?: Scholar Rock's prepaid & other current increased by 69.3% year-over-year, from $20.87M to $35.34M.
What is the long-term trend for Scholar Rock's prepaid & other current?: Over 5 years (2020 to 2025), Scholar Rock's prepaid & other current has grown at a 39.1% compound annual growth rate (CAGR), from $3.37M to $17.58M.
What does prepaid & other current mean?: Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.